NCT03032250

Brief Summary

This pilot clinical trial studies how well Prepare to Care kit works in improving caregiver support in patients with stage I-IV head and neck cancer that is new or has come back. Prepare to Care kit may increase knowledge about head and neck cancer and enhance stress-management skills.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 15, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2020

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

July 1, 2021

Completed
Last Updated

January 9, 2023

Status Verified

December 1, 2022

Enrollment Period

2.9 years

First QC Date

January 17, 2017

Results QC Date

April 23, 2021

Last Update Submit

December 14, 2022

Conditions

CaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Lip and Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell CarcinomaStage II Hypopharyngeal Squamous Cell CarcinomaStage II Laryngeal Squamous Cell CarcinomaStage II Lip and Oral Cavity Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Lip and Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IV Hypopharyngeal Squamous Cell CarcinomaStage IV Laryngeal Squamous Cell CarcinomaStage IV Lip and Oral Cavity Squamous Cell CarcinomaStage IV Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Lip and Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IVB Lip and Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Hypopharyngeal Squamous Cell CarcinomaStage IVC Laryngeal Squamous Cell CarcinomaStage IVC Lip and Oral Cavity Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal SCCRecurrent Paranasal Sinus Squamous Cell Carcinoma

Outcome Measures

Primary Outcomes (10)

  • Number of Participants Noting Quite a Bit/Very Much Helpful to Survey Questions

    10-item quantitative survey will be developed for study to assess how much caregivers liked different aspects of the intervention. Acceptability will be summarized quantitatively and qualitatively. These acceptability questions were asked only of caregivers in the intervention group - Group 1 Supportive Care (Prepare to Care Kit). All data is based on participants answering the acceptability questions as "Quite a Bit/Very Much Helpful" for the intervention materials. Not all participants answered this part of the outcome measure.

    Six weeks post radiation therapy

  • Accrual Assessed by Number of Caregivers Who Agreed to Participate Divided by the Number of Months of Recruitment

    38 patient/caregiver dyads agreed to participate, 22 months of recruitment, for accrual rate of 1.7 (caregiver) participants per month

    Up to 1 year

  • Change in Caregiver Burden Assessed by Caregiver Reaction Assessment (CRA)

    21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Minimum and maximum scoring scale: BASELINE: Scores for esteem 15-31; lack of family support 5-15, impact of finances 3-12, impact of schedule 12-23, impact of health 11-16). AFTER RADIOTHERAPY: Scores for esteem 20-31; lack of family support 9-17, impact of finances 7-11, impact of schedule 14-22, impact of health 12-17). The higher the score the more the item being assessed impacted the participant.

    Baseline and following radiotherapy, assessed up to 1 year

  • Change in Psychological Distress - Center for Epidemiological Studies Depression (CESD)

    The score is the sum of the 20 questions. Possible scoring range is 0-60. A score of 16 points or more is considered depressed.

    Before and after radiotherapy, assessed up to 1 year

  • Change in Quality of Life Assessed by Caregiver Quality of Life Index-Cancer (CqoL-Canc)

    35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns). The Cqol-Canc has demonstrated validity and reliability. Minimum and maximum score at baseline is a range of 9-78 and after radiotherapy a range of 2-73. The higher the score the greater the level of change in the quality of life for participants.

    Before and after radiotherapy, assessed up to 1 year

  • Frequency of Intervention Modules Utilized Assessed by Caregiver Logs

    Data on intervention resources used and time spent using them based on caregivers in intervention group

    Up to 1 year

  • Number of Participants in Agreement to Perform Interventions

    Participation assessed by number of eligible participants who agreed to participate and complete study interventions.

    Up to 1 year

  • Retention Assessed by Number of Participants Who Completed the End of Radiotherapy Visit Divided by the Number Who Agreed to Participate

    Up to 1 year

  • Self-efficacy in Abbreviated Progressive Muscle Relaxation (APMR)

    A 3-item instrument developed for study to evaluate self-efficacy in APMR. Minimum to maximum scores range from 3-27. Higher scores demonstrate higher self efficacy in participants.

    At baseline and up to the end of radiotherapy, assessed up to 1 year

  • Self-efficacy in Coping With Cancer Caregiver Inventory

    21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions); demonstrated validity and reliability. Minimum and maximum scores range from 10-63. Higher scores indicate higher self-efficacy in coping with cancer from the participants.

    At baseline and up to the end of radiotherapy, assessed up to 1 year

Other Outcomes (1)

  • Salivary Cortisol Collection

    Up to 1 year

Study Arms (2)

Group I Supportive Care (Prepare to Care kit)

EXPERIMENTAL

Caregivers watch introduction video on a DVD over 10 minutes at baseline. Caregivers receive Prepare to Care kit including 8 workbook modules and complete at least 1 module over 30-45 minutes each week. Caregivers also attend interventionist session over 10-30 minutes weekly.

Other: Communication InterventionOther: Watch videoOther: Module completion of the Prepare to Care kitOther: Quality-of-Life AssessmentOther: Survey AdministrationOther: Salivary cortisol collection

Group II Control Group

EXPERIMENTAL

Caregivers received standard of care throughout course of intervention, with option to receive study intervention at end of study

Other: Watch videoOther: Module completion of the Prepare to Care kitOther: Quality-of-Life AssessmentOther: Survey AdministrationOther: Salivary cortisol collection

Interventions

Attend interventionist sessions

Group I Supportive Care (Prepare to Care kit)

Watch video on a DVD

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Group I Supportive Care (Prepare to Care kit)Group II Control Group

Complete modules of the Prepare to Care kit

Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Group I Supportive Care (Prepare to Care kit)Group II Control Group

Ancillary studies

Also known as: Quality of Life Assessment
Group I Supportive Care (Prepare to Care kit)Group II Control Group

Ancillary studies

Group I Supportive Care (Prepare to Care kit)Group II Control Group

Obtained at three times a day (at awakening, 30 minutes post awakening and bedtime) for two consecutive days for eligible caregivers in both groups. Samples collected by placing a cotton ball under the tongue for approximately 1-2 minutes which is subsequently stored in a plastic tube and refrigerated.

Group I Supportive Care (Prepare to Care kit)Group II Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CAREGIVERS:
  • CARE-RECIPIENTS:
  • Has a new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV squamous cell carcinoma of the upper aerodigestive tract (including lip/oral cavity, nasopharynx, salivary gland, oropharynx, hypopharynx, paranasal sinus, and larynx cancers)
  • Has planned external beam radiotherapy (+/- chemotherapy) for 6-7 weeks
  • Has an informal (unpaid) caregiver during radiation therapy who is participating in study

You may not qualify if:

  • CAREGIVERS: Has a current cancer diagnosis
  • CAREGIVERS: Cannot read/communicate in English
  • CAREGIVERS: Have an endocrine disorder (e.g., diabetes and thyroid disorders), or is currently taking a steroid based medication will not be eligible to participate in the saliva portion of the study
  • CARE-RECIPIENTS: Cannot read/communicate in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Comprehensive Cancer Center of Wake Forest University

Winston-Salem, North Carolina, 27157, United States

Location

Related Publications (1)

  • Nightingale C, Sterba KR, Levine B, Tooze JA, Greven K, Frizzell B, Hughes RT, Snavely A, Lesser GJ, Norona S, Pleasant K, Weaver KE. Feasibility and Acceptability of a Multi-Modality Self-Management Intervention for Head and Neck Cancer Caregivers: A Pilot Randomized Trial. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221098984. doi: 10.1177/15347354221098984.

MeSH Terms

Conditions

Head and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckLymphoid Interstitial Pneumonia

Interventions

Educational StatusMethods

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsCarcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation CharacteristicsInvestigative Techniques

Results Point of Contact

Title
Principal Investigator
Organization
Wake Forest Baptist Comprehensive Cancer Center

Study Officials

  • Chandylen Nightingale

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2017

First Posted

January 26, 2017

Study Start

May 15, 2017

Primary Completion

April 10, 2020

Study Completion

April 10, 2020

Last Updated

January 9, 2023

Results First Posted

July 1, 2021

Record last verified: 2022-12

Locations